A randomized phase II efficacy and correlative studies of cetuximab with or without sorafenib in recurrent and/or metastatic head and neck squamous cell carcinoma

Jill Gilbert, Michael J. Schell, Xiuhua Zhao, Barbara Murphy, Tawee Tanvetyanon, Marino E. Leon, D. Neil Hayes, Missak Haigentz, Nabil Saba, Jorge Nieva, Justin Bishop, David Sidransky, Rajani Ravi, Atul Bedi, Christine H. Chung

Research output: Contribution to journal › Article › peer-review

50 Scopus citations

Fingerprint

Dive into the research topics of 'A randomized phase II efficacy and correlative studies of cetuximab with or without sorafenib in recurrent and/or metastatic head and neck squamous cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences